We are rebuilding biotech for the AI era. When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected
At Ripple, we’re building a world where value moves like information does today. It’s big, it’s bold, and we’re already doing it. Through our crypto solutions for financial institutions, businesses, governments and developers, we are improving
embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than
Company A1 is building a proactive AI smart assistant for everyday users to bring intelligence to conversations, errands, organising and workflows. Our product focuses on achieving high reliability for long-running workflows, persistent context, and real-world task
Our Vision & Products EverAI — Building the Future of AI Companionship One of the Top 15 Largest & Fastest-Growing AI Companies in the World 50 Million Users in 2 years — Help Us Reach 100M
Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department.
Company Description Welcome to SMG Swiss Marketplace Group! SMG is a pioneering network of online marketplaces and a leading European digital company that simplifies people’s lives with forward-looking products. We operate leading marketplaces across real estate,
Bei der Zuger Kantonalbank zählen Mut, Leistungsbereitschaft und Engagement. Wir suchen Persönlichkeiten, die Verantwortung übernehmen und gemeinsam mit uns ambitionierte Ziele verwirklichen. Als führendes Finanzinstitut im Kanton Zug bieten wir ein dynamisches Umfeld mit einer spannenden,
Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
About kaiko.ai Kaiko is building a next-generation agentic clinical AI assistant that helps clinicians reason across patient data, guidelines, and diagnostics. Healthcare decisions are rarely made by a single person or from a single data source.
Position: SAP HR Payroll Consultant (Swiss Payroll) Location: Switzerland, Austria, Germany, Poland (Remote) The Role As part of our Professional Services Consulting team DACH we are looking for candidates with Swiss SAP Payroll experience for client
Company Description Yuh - The most complete financial app of Switzerland. Yuh is the app to pay, save and invest.Since 2021, the company is helping you manage your finances transparently, responsibly and in full freedom in
Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)